- Report
- November 2025
- 160 Pages
Global
From €2935EUR$3,160USD£2,456GBP
€3669EUR$3,950USD£3,069GBP
- Report
- September 2026
- 157 Pages
Global
From €3500EUR$4,036USD£3,031GBP
- Report
- July 2026
- 120 Pages
Global
From €4505EUR$4,850USD£3,769GBP
- Report
- December 2025
- 160 Pages
Global
From €4505EUR$4,850USD£3,769GBP
- Report
- December 2025
- 142 Pages
Global
From €4505EUR$4,850USD£3,769GBP
- Report
- September 2026
- 351 Pages
Global
From €3500EUR$4,036USD£3,031GBP
- Report
- September 2026
- 131 Pages
Global
From €3500EUR$4,036USD£3,031GBP
- Report
- August 2026
- 111 Pages
Global
From €3500EUR$4,036USD£3,031GBP
- Report
- April 2026
- 115 Pages
Global
From €3500EUR$4,036USD£3,031GBP
- Report
- April 2026
- 107 Pages
Global
From €3500EUR$4,036USD£3,031GBP
- Report
- April 2026
- 103 Pages
Global
From €3500EUR$4,036USD£3,031GBP
- Report
- March 2026
- 127 Pages
Global
From €3500EUR$4,036USD£3,031GBP
- Report
- February 2026
- 170 Pages
Global
From €4505EUR$4,850USD£3,769GBP
- Report
- December 2025
- 150 Pages
Global
From €4505EUR$4,850USD£3,769GBP
- Report
- November 2025
- 150 Pages
Global
From €4505EUR$4,850USD£3,769GBP
- Report
- February 2026
- 186 Pages
Global
From €4505EUR$4,850USD£3,769GBP
- Report
- November 2025
- 150 Pages
Global
From €4505EUR$4,850USD£3,769GBP
- Report
- November 2025
- 150 Pages
Global
From €4505EUR$4,850USD£3,769GBP
- Report
- March 2026
- 238 Pages
Global
From €1718EUR$1,850USD£1,438GBP
- Report
- November 2025
- 112 Pages
Global
From €3205EUR$3,450USD£2,681GBP

The Eye Disease market within the Optical industry is a rapidly growing sector, with a focus on providing treatments and solutions for a variety of eye conditions. This includes the diagnosis and management of conditions such as glaucoma, cataracts, macular degeneration, and diabetic retinopathy. Companies in this market are developing innovative technologies to improve the accuracy and speed of diagnosis, as well as treatments to improve patient outcomes.
The Eye Disease market is also focused on providing solutions to improve patient access to care, such as telemedicine and remote monitoring. This is helping to reduce the burden on healthcare systems and improve patient outcomes.
Companies in the Eye Disease market include Alcon, Bausch + Lomb, Carl Zeiss Meditec, Essilor, Hoya, Johnson & Johnson Vision, Novartis, and Topcon. Show Less Read more